Elevated C-reactive protein levels in overweight and obese adults

Journal of the American Medical Association

Volumn 282, Issue 22, 1999, Pages 2131-2135

  Visser, Marjolein ^a,b   Bouter, Lex M ^a   McQuillan, Geraldine M ^c   Wener, Mark H ^d   Harris, Tamara B ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ESTROGEN; INTERLEUKIN 6;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ARTICLE; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; HEALTH STATISTICS; HEALTH STATUS; HEALTH SURVEY; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SMOKING HABIT;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HEALTH SURVEYS; HUMANS; INFLAMMATION; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY;

EID: 0033537013     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.22.2131     Document Type: Article

References (46)

1. Flier JS. The adipocyte: storage depot or node on the energy information superhighway? Cell. 1995; 80:15-18.
2. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998;22:1145-1158.
3. Purohit A, Ghilchik MW, Duncan L, et al. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab. 1995;80:3052-3058.
4. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab. 1997;82:4196-4200.
5. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6. J Clin Endocrinol Metab. 1998; 83:847-850.
6. Banks RE, Forbes MA, Storr M, et al. The acute phase response in patients receiving subcutaneous IL-6. Clin Exp Immunol 1995;102:217-223.
7. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998;128: 127-137.
8. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. JAMA. 1998; 279:1477-1482.
9. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 1996;144:537-547.
10. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
11. Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731-733.
12. Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation. 1999;99:237-242.
13. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425-428.
14. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Hyattsville, Md: National Center for Health Statistics; 1994.
15. Lohman TG, Roche AF, Martorell R, eds. Anthropometric Standardization Reference Manual. Champaign, III: Human Kinetics Books; 1988.
16. Keys A, Fidanza F, Karvonen MJ, et al. Indices of relative weight and obesity. J Chronic Dis. 1972;25:329-343.
17. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. JAMA. 1994;272:205-211.
18. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, Md: National Institutes of Health; 1998. Available at: http://www.nhlbi.nih.gov/ guidelines.
19. Schreiner PJ, Terry JG, Evans GW, Hinson WH, Crouse JR III, Heiss G. Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices. Am J Epidemiol. 1996;144:335-345.
20. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. Exposure of the US population to environmental tobacco smoke. JAMA. 1996;275:1233-1240.
21. Bernert JT, Sosnoff C, Turner WE, et al. Development of a rapid and sensitive method for serum cotinine analysis as a marker of exposure to environmental tobacco smoke [abstract]. Clin Chem. 1994;40:1075.
22. Wener MH, Mannik M. Rheumatoid factors. In: Rose NR, Conway de Macario E, Fahey JL, et al, eds. Manual of Clinical Laboratory Immunology. 5th ed. Washington, DC: American Society for Microbiology; 1997.
23. Rose G, Blackburn H, Gillum R, et al. Cardiovascular Survey Methods. Geneva, Switzerland: World Health Organization; 1982.
24. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
25. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. Diabetes Care. 1998;21:518-524.
26. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors. BMJ. 1996;312:1061-1065.
27. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reartive protein to risk of cardiovascular disease in the elderly. Arterioscler Thromb Vasc Biol. 1997;17:1121-1127.
28. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system. Diabetologia. 1997;40:1286-1292.
29. Zhang J, Yu KF. What's the relative risk? a method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690-1691.
30. Third National Health and Nutrition Examination Survey, 1988-1994, Reference Manuals and Reports [CD-ROM]. Hyattsville, Md: Centers for Disease Control and Prevention; 1996.
31. Cassano PA, Rosner B, Vokonas PS, Weiss ST. Obesity and body fat distribution in relation to the incidence of non-insulin-dependent diabetes mellitus. Am J Epidemiol. 1992;136:1474-1486.
32. Voigt LF, Koepsell TD, Nelson JL, et al. Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology. 1994;5:525-532.
33. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. 1995;141:1117-1127.
34. Blackburn WD Jr. Validity of acute-phase proteins as markers of disease activity. J Rheumatol Suppl. 1994;42:9-13.
35. Pi-Sunyer FX. Health implications of obesity. Am J Clin Nutr. 1991;53:1595S-1603S.
36. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280:1843-1848.
37. Folsom AR, Stevens J, Schreiner PJ, McGovern PG. Body mass index, waist/hip ratio, and coronary heart disease incidence in African-Americans and whites. Am J Epidemiol. 1998;148:1187-1194.
38. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
39. Anzai T, Yoshikawa T, Shiraki H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation. 1997;96:778-784.
40. Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82:513-520.
41. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512.
42. Gallagher D, Visser M, Sepúlveda D, et al. How useful is body mass index for comparison of body fatness across age, gender, and ethnic groups? Am J Epidemiol. 1996;143:228-239.
43. Clark GH, Fraser CG. Biological variation of acute phase proteins. Ann Clin Biochem. 1993;30:373-376.
44. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects. Clin Chem. 1997;43:52-58.
45. Sebastiàn-Gàmbaro ME, Liròn-Hernàndez FJ, Fuentes-Arderiu X. Intra-and inter-individual biological variability data bank. Eur J Clin Chem Clin Biochem. 1997;35:845-852.
46. Franzini C. Need for correct estimates of biological variation. Clin Chem Lab Med. 1998;36:131-132.